| 2025-07-31 | -19.7% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2025-07-31 | -19.7% | news | Yahoo Finance | Why Baxter (BAX) Stock Is Falling Today - Yahoo Finance |
| 2025-07-31 | -19.7% | earnings | Yahoo Finance | Baxter’s (NYSE:BAX) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops - Yahoo Finance |
| 2025-07-31 | -19.7% | earnings | Seeking Alpha | Baxter International stock slumps on Q2 miss (BAX:NYSE) - Seeking Alpha |
| 2023-01-06 | -17.2% | legal | SEC EDGAR | BAX 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-10-30 | -16.8% | earnings | Seeking Alpha | Baxter International Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-10-30 | -16.8% | earnings | Seeking Alpha | Baxter signals 2026 dividend reduction and updates full-year 2025 earnings guidance amid operational challenges |
| 2025-10-30 | -16.8% | earnings | Seeking Alpha | Baxter International Inc. (BAX) Q3 2025 Earnings Call Transcript |
| 2025-10-30 | -16.8% | earnings | Seeking Alpha | Baxter tanks after lower FY expectations, Q3 revenue miss |
| 2025-10-30 | -16.8% | earnings | Seeking Alpha | Baxter reports mixed Q3 results; initiates Q4 and updates FY outlook |
| 2025-10-30 | -16.8% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2025-10-30 | -16.8% | news | Yahoo Finance | Why Baxter (BAX) Stock Is Falling Today - Yahoo Finance |
| 2025-10-30 | -16.8% | earnings | Yahoo Finance | Baxter International (BAX) Beats Q3 Earnings Estimates - Yahoo Finance |
| 2025-10-30 | -16.8% | earnings | Yahoo Finance | Baxter (NYSE:BAX) Reports Sales Below Analyst Estimates In Q3 Earnings, Stock Drops 13.5% - Yahoo Finance |
| 2025-10-30 | -16.8% | earnings | ChartMill | Baxter International Inc (NYSE:BAX) Stock Plummets 10.8% on Q3 Revenue Miss and Cautious Outlook - ChartMill |
| 2025-10-30 | -16.8% | earnings | Seeking Alpha | Baxter tanks after lower FY expectations, Q3 revenue miss (BAX:NYSE) - Seeking Alpha |
| 2025-10-30 | -16.8% | news | StocksToTrade | Baxter Faces Legal Heat, Stock Tanks - StocksToTrade |
| 2025-10-29 | -15.1% | earnings | Seeking Alpha | Baxter Q3 2025 Earnings Preview |
| 2025-10-29 | -15.1% | news | TMX Newsfile | BAX STOCK LOSS NOTICE: Baxter International Inc. Investors are Notified they may have been Affected by Fraud and are Urged to Contact BFA Law - TMX Newsfile |
| 2022-07-28 | -14.9% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2026-02-11 | -13.2% | earnings | Seeking Alpha | Baxter Q4 2025 Earnings Preview |
| 2025-02-20 | +11.9% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2024-05-02 | -10.7% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2026-02-17 | +9.8% | analyst | MarketWatch | Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2023-02-09 | -9.7% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2026-02-12 | -9.7% | earnings | Seeking Alpha | Baxter International: Debt, Margin Pressure, Dreadful FY26 Guidance (Downgrade) |
| 2026-02-12 | -9.7% | earnings | Seeking Alpha | Baxter outlines 2026 EPS target of $1.85–$2.05 and signals flat organic sales as company pursues turnaround |
| 2026-02-12 | -9.7% | earnings | Seeking Alpha | Baxter International Inc. (BAX) Q4 2025 Earnings Call Transcript |
| 2026-02-12 | -9.7% | earnings | Seeking Alpha | Baxter slips following Q4 bottom line miss, weak 2026 EPS guidance |
| 2026-02-12 | -9.7% | earnings | Seeking Alpha | Baxter International Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-12 | -9.7% | earnings | Seeking Alpha | Baxter Non-GAAP EPS of $0.44 misses by $0.10, revenue of $2.97B beats by $150M |
| 2026-02-12 | -9.7% | legal | SEC EDGAR | BAX 8-K: 2.02, 5.02, 8.01 (SEC Filing) |
| 2026-02-12 | -9.7% | earnings | ChartMill | Baxter International Inc (NYSE:BAX) Stock Plummets on Q4 Earnings Miss and Weak 2026 Outlook - ChartMill |
| 2026-02-12 | -9.7% | earnings | Yahoo Finance | BAX Stock Falls Following Q4 Earnings Miss, Margins Contract - Yahoo Finance |
| 2026-02-12 | -9.7% | news | The Motley Fool | Why Baxter International Stock Was Tumbling Today - The Motley Fool |
| 2026-02-12 | -9.7% | earnings | Seeking Alpha | Baxter International: Debt, Margin Pressure, Dreadful FY26 Guidance (Downgrade) (NYSE:BAX) - Seeking Alpha |
| 2026-02-12 | -9.7% | earnings | Seeking Alpha | Baxter International Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:BAX) 2026-02-12 - Seeking Alpha |
| 2026-02-12 | -9.7% | earnings | marketscreener.com | Earnings Flash (BAX) Baxter International Inc. Reports Q4 Revenue $2.97B, vs. FactSet Est of $2.82B - marketscreener.com |
| 2026-02-12 | -9.7% | news | MarketWatch | Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch |
| 2026-02-12 | -9.7% | earnings | TipRanks | Baxter International Reports Mixed Q4 Results and Outlook - TipRanks |
| 2026-02-12 | -9.7% | earnings | marketscreener.com | Earnings Flash (BAX) Baxter International Inc. Posts Q4 Adjusted EPS $0.44 per Share, vs. FactSet Est of $0.52 - marketscreener.com |
| 2026-02-12 | -9.7% | earnings | Benzinga | Baxter Shares Tank, 2026 Profit Guidance Lower Than Expected - Baxter International (NYSE:BAX) - Benzinga |
| 2026-02-03 | +7.2% | earnings | Yahoo Finance | Here’s What Hit Baxter (BAX) in Q4 - Yahoo Finance |
| 2026-01-12 | -6.7% | news | Seeking Alpha | Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2026-01-12 | -6.7% | news | TradingView | Why Baxter (BAX) Stock Is Trading Lower Today - TradingView |
| 2026-01-12 | -6.7% | news | bitget.com | Why Baxter (BAX) Shares Are Down Today - bitget.com |
| 2026-01-12 | -6.7% | news | MarketWatch | Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch |
| 2022-10-27 | -6.4% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2021-09-02 | +6.3% | legal | SEC EDGAR | BAX 8-K: 1.01, 7.01, 8.01 (SEC Filing) |
| 2024-08-13 | -5.8% | legal | SEC EDGAR | BAX 8-K: 1.01, 5.02, 7.01 (SEC Filing) |
| 2024-11-08 | -5.6% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2021-07-29 | -5.5% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2025-10-31 | -5.5% | news | TradingView | Why Baxter (BAX) Shares Are Sliding Today - TradingView |
| 2024-08-06 | +5.4% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2025-11-11 | +5.1% | news | Seeking Alpha | Baxter declares $0.01 dividend |
| 2025-11-11 | +5.1% | news | GlobeNewswire | Baxter International Stockholders with Large Losses Should - GlobeNewswire |
| 2026-04-16 | +4.8% | news | Simply Wall St. | Is It Time To Reassess Baxter International (BAX) After A 35.9% One Year Share Price Slide |
| 2021-10-28 | -4.8% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2026-03-11 | +4.8% | news | Seeking Alpha | Baxter International Inc. (BAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript |
| 2022-05-06 | +4.6% | legal | SEC EDGAR | BAX 8-K: 3.03, 5.02, 5.03, 5.07 (SEC Filing) |
| 2026-02-16 | +4.6% | news | DirectorsTalk Interviews | Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 9.31% Potential Upside - DirectorsTalk Interviews |
| 2025-12-12 | +4.6% | legal | Yahoo Finance | Baxter International Stock: Is BAX Underperforming the Health Care Sector? - Yahoo Finance |
| 2023-07-27 | -4.3% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2026-01-05 | +4.1% | news | Yahoo Finance | Artisan Mid Cap Value Fund’s Views on Baxter International (BAX) - Yahoo Finance |
| 2025-11-12 | +4.1% | legal | SEC EDGAR | BAX 8-K: 5.02 (SEC Filing) |
| 2025-11-14 | -4.0% | analyst | Yahoo Finance | Argus Research Downgrades Baxter International Inc. (BAX)’s Rating To Hold Following Dividend Cut - Yahoo Finance |
| 2023-05-09 | -3.9% | legal | SEC EDGAR | BAX 8-K: 1.01, 5.02, 5.03, 7.01 (SEC Filing) |
| 2026-03-18 | -3.8% | news | Yahoo Finance | How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks? - Yahoo Finance |
| 2025-05-01 | -3.7% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2021-12-13 | +3.6% | legal | SEC EDGAR | BAX 8-K: 2.01, 5.02, 7.01 (SEC Filing) |
| 2026-03-19 | -3.6% | executive | Stock Titan | Baxter (NYSE: BAX) details 2025 performance, new CEO and leverage goals - Stock Titan |
| 2025-10-28 | -3.6% | news | GlobeNewswire | SHAREHOLDER ALERT: Baxter International Inc. (NYSE:BAX) - GlobeNewswire |
| 2025-02-03 | -3.5% | legal | SEC EDGAR | BAX 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2025-02-03 | -3.5% | legal | SEC EDGAR | BAX 8-K: 2.01, 5.02 (SEC Filing) |
| 2021-12-02 | +3.3% | legal | SEC EDGAR | BAX 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-03-06 | -3.3% | news | Seeking Alpha | Sticking With Baxter At The Lows |
| 2026-03-06 | -3.3% | news | Seeking Alpha | Sticking With Baxter At The Lows (NYSE:BAX) - Seeking Alpha |
| 2026-01-02 | +3.2% | analyst | Yahoo Finance | What Do Analysts Think About Baxter International Inc. (BAX)? - Yahoo Finance |
| 2025-01-31 | -3.2% | legal | SEC EDGAR | BAX 8-K: 5.02 (SEC Filing) |
| 2026-03-27 | -3.2% | analyst | Yahoo Finance | Bank of America Maintains a Hold Rating on Baxter International (BAX) - Yahoo Finance |
| 2026-04-21 | -3.2% | news | Stock Titan | Pzena shows 65.35M Baxter (NYSE: BAX) shares; 12.7% ownership - Stock Titan |
| 2026-04-21 | -3.2% | news | Forbes | Baxter International - Forbes |
| 2025-12-18 | -3.1% | news | Yahoo Finance | Baxter International Inc. (BAX): A Bull Case Theory - Yahoo Finance |
| 2025-08-04 | +3.0% | analyst | Yahoo Finance | Are Wall Street Analysts Bullish on Baxter International Stock? - Yahoo Finance |
| 2025-09-29 | +2.9% | news | Seeking Alpha | Baxter International: Medical Business In Need Of A Save Itself (NYSE:BAX) - Seeking Alpha |
| 2025-11-19 | -2.9% | legal | SEC EDGAR | BAX 8-K: 8.01 and (SEC Filing) |
| 2025-11-19 | -2.9% | expansion | Stock Titan | Baxter (NYSE: BAX) Launches $750M and $300M Tender Offers for Senior Notes - Stock Titan |
| 2026-03-14 | -2.9% | news | simplywall.st | Is Baxter International (BAX) Now Attractive After Steep Multi Year Share Price Declines? - simplywall.st |
| 2026-03-24 | +2.9% | news | Reuters | EU regulator flags Baxter cancer drug shortage until early next year - Reuters |
| 2026-03-23 | +2.8% | executive | Quiver Quantitative | BAXTER INTERNATIONAL INC ($BAX) Former Chair of the Board, President and CEO 2025 Pay Revealed - Quiver Quantitative |
| 2026-02-10 | +2.8% | earnings | TradingView | Baxter to Post Q4 Earnings: What's in Store for the Stock? - TradingView |
| 2026-02-10 | +2.8% | earnings | TradingView | Baxter (BAX) Q4 Earnings: What To Expect - TradingView |
| 2026-01-16 | -2.7% | earnings | Seeking Alpha | Mega-to-large cap healthcare stocks with the weakest earnings momentum |
| 2026-01-16 | -2.7% | earnings | Seeking Alpha | Mega-to-large cap healthcare stocks with the weakest earnings momentum (BAX:NYSE) - Seeking Alpha |
| 2026-02-18 | +2.7% | analyst | MarketWatch | Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-03-30 | +2.6% | news | Stock Titan | Baxter rolls out barcode IV labels aimed at cutting bedside errors - Stock Titan |
| 2026-02-06 | -2.6% | news | Seeking Alpha | Large-cap stocks with lowest dividend growth grade |
| 2025-10-20 | -2.5% | legal | GlobeNewswire | BAX CLASS ACTION LAWSUIT: Baxter International Inc. - GlobeNewswire |
| 2025-11-25 | +2.4% | legal | SEC EDGAR | BAX 8-K: 1.01 and (SEC Filing) |
| 2025-11-25 | +2.4% | news | GlobeNewswire | BAX Class Action Reminder – Robbins LLP Reminds Baxter - GlobeNewswire |
| 2025-12-04 | -2.1% | legal | SEC EDGAR | BAX 8-K: 1.01, 1.02, 2.03, 8.01 (SEC Filing) |
| 2026-04-15 | +2.1% | news | StockStory | 3 Value Stocks We Find Risky |
| 2023-03-13 | +2.0% | legal | SEC EDGAR | BAX 8-K: 1.01 and (SEC Filing) |
| 2025-07-18 | -2.0% | news | simplywall.st | Further weakness as Baxter International (NYSE:BAX) drops 6.1% this week, taking five-year losses to 65% - simplywall.st |
| 2025-11-21 | +1.9% | analyst | TIKR.com | Baxter International Stock Prediction: Where Analysts See the Stock Going by 2027 - TIKR.com |
| 2025-11-03 | -1.9% | news | Seeking Alpha | SA Graphics: These were the top S&P 500 gainers and losers in October |
| 2025-11-03 | -1.9% | earnings | IndexBox | Baxter International (BAX) Stock Plunges on Q3 2025 Revenue Miss and Guidance Cut - News and Statistics - IndexBox |
| 2026-03-22 | +1.8% | M&A | AD HOC NEWS | Baxter International Inc stock faces renewed pressure amid kidney care segment challenges and acquis - AD HOC NEWS |
| 2021-11-30 | +1.8% | legal | SEC EDGAR | BAX 8-K: 5.02 and (SEC Filing) |
| 2025-06-12 | -1.8% | legal | SEC EDGAR | BAX 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2025-12-05 | -1.6% | news | Yahoo Finance | SCCM Enhanced Equity Income Fund Sold Baxter Int’l (BAX) Due to Near-Term Headwinds - Yahoo Finance |
| 2025-12-05 | -1.6% | news | Benzinga | Baxter International Inc (BAX) Stock Price Prediction: 2025, 2026, 2030 - Benzinga |
| 2025-08-13 | +1.6% | news | Yahoo Finance | Here’s Why You Should Consider Selling Your Baxter (BAX) Shares - Yahoo Finance |
| 2025-11-02 | -1.6% | news | Yahoo Finance | Is Wall Street Bullish or Bearish on Baxter International Stock? - Yahoo Finance |
| 2025-11-01 | -1.6% | earnings | Seeking Alpha | Earnings Scorecard: 24 out of 25 healthcare firms deliver EPS wins this week |
| 2026-01-19 | -1.6% | news | DirectorsTalk Interviews | Baxter International Inc. (BAX) Stock Analysis: Exploring a 15% Potential Upside Amidst Strategic Global Operations - DirectorsTalk Interviews |
| 2026-01-19 | -1.6% | earnings | FinancialContent | What You Need To Know Ahead of Baxter International's Earnings Release - FinancialContent |
| 2026-01-17 | -1.6% | news | Seeking Alpha | The Bottom Fishing Club - Baxter: Defensive Pick, Restructuring And Paying Down Debt |
| 2026-01-17 | -1.6% | news | Seeking Alpha | The Bottom Fishing Club - Baxter: Defensive Pick, Restructuring And Paying Down Debt (BAX) - Seeking Alpha |
| 2025-12-02 | -1.5% | news | Seeking Alpha | Baxter International Inc. (BAX) Presents at Evercore 8th Annual Healthcare Conference Transcript |
| 2026-01-31 | -1.5% | earnings | IndexBox | Baxter Stock Performance & 2025 Outlook: Earnings, Analyst Ratings, Price Target - News and Statistics - IndexBox |
| 2021-04-29 | -1.5% | legal | SEC EDGAR | BAX 8-K: 8.01 and (SEC Filing) |
| 2021-04-29 | -1.5% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2023-02-14 | -1.4% | legal | SEC EDGAR | BAX 8-K: 5.02 and (SEC Filing) |
| 2022-04-28 | +1.2% | legal | SEC EDGAR | BAX 8-K: 8.01 and (SEC Filing) |
| 2022-04-28 | +1.2% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2025-12-22 | -1.2% | legal | SEC EDGAR | BAX 8-K: 8.01 (SEC Filing) |
| 2025-10-24 | -1.2% | news | GlobeNewswire | BAX CLASS ACTION: Baxter International Inc. Hit with - GlobeNewswire |
| 2026-04-23 | -1.2% | earnings | Zacks | Analysts Estimate Baxter International (BAX) to Report a Decline in Earnings: What to Look Out for |
| 2026-04-23 | -1.2% | news | GlobeNewswire | Long-Term Care and Home Healthcare Global Market Analysis and Technology Research Report 2026-2030, Profiles of Leading Players - Baxter, Medtronic, Koninklijke Philips, ResMed, Sunrise Medical |
| 2026-04-23 | -1.2% | earnings | UBND thành phố Hải Phòng | BAX (Baxter International Inc.) notches 5.7 percent Q4 2025 revenue growth as shares trade slightly higher despite EPS miss. - Hedge Fund Inspired Picks - UBND thành phố Hải Phòng |
| 2024-09-03 | +1.2% | legal | SEC EDGAR | BAX 8-K: 5.02 (SEC Filing) |
| 2023-10-02 | -1.2% | legal | SEC EDGAR | BAX 8-K: 2.01 and 7.01 (SEC Filing) |
| 2025-12-26 | +1.1% | news | Yahoo Finance | Reasons to Retain Baxter International Stock in Your Portfolio Now - Yahoo Finance |
| 2025-12-26 | +1.1% | news | Zacks Investment Research | Reasons to Retain Baxter International Stock in Your Portfolio Now - Zacks Investment Research |
| 2026-01-20 | -1.1% | news | Seeking Alpha | Baxter International: Transition Year With No Immediate Catalysts |
| 2026-01-20 | -1.1% | news | Yahoo Finance | Assessing Baxter International (BAX) Valuation After Mixed Short And Long Term Shareholder Returns - Yahoo Finance |
| 2026-01-20 | -1.1% | news | Seeking Alpha | Baxter International: Transition Year With No Immediate Catalysts (NYSE:BAX) - Seeking Alpha |
| 2026-04-22 | -1.1% | earnings | Motley Fool | Baxter (BAX) Q4 2024 Earnings Call Transcript |
| 2026-04-09 | -1.0% | news | Stock Titan | Baxter (NYSE: BAX) exec holds 31K shares plus 25.9K options - Stock Titan |
| 2026-04-09 | -1.0% | executive | Stock Titan | Baxter (NYSE: BAX) surgery chief lists common shares and option grants - Stock Titan |
| 2026-04-09 | -1.0% | news | Stock Titan | [Form 3] BAXTER INTERNATIONAL INC Initial Statement of Beneficial Ownership - Stock Titan |
| 2026-01-28 | +1.0% | news | Finviz | Reasons to Retain Baxter International Stock in Your Portfolio Now - Finviz |
| 2026-01-07 | +1.0% | news | Quiver Quantitative | Fund Update: 4,404,874 BAXTER INTERNATIONAL (BAX) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative |
| 2025-06-21 | -1.0% | news | simplywall.st | Baxter International Inc.'s (NYSE:BAX) Shares Lagging The Industry But So Is The Business - simplywall.st |
| 2025-10-22 | +1.0% | news | GlobeNewswire | BAX STOCK NOTICE: Baxter International Inc. Investors with - GlobeNewswire |
| 2026-04-08 | +1.0% | news | Business Wire | Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors |
| 2026-04-08 | +1.0% | executive | MedTech Dive | Hologic hires former Baxter leader José Almeida as CEO |
| 2026-04-08 | +1.0% | news | Stock Titan | Baxter schedules April 30 webcast for first-quarter 2026 results - Stock Titan |
| 2026-04-07 | +1.0% | news | StockStory | 2 Oversold Stocks Set for a Comeback and 1 We Brush Off |
| 2026-03-25 | +0.9% | news | Stock Titan | Therapy animals will reach 100,000 patients and care teams in pilot - Stock Titan |
| 2024-09-09 | -0.9% | legal | SEC EDGAR | BAX 8-K: 5.02 and (SEC Filing) |
| 2026-04-19 | +0.9% | earnings | Barchart | Baxter International Earnings Preview: What to Expect |
| 2026-04-18 | +0.9% | news | StockStory | Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know |
| 2026-04-06 | -0.9% | news | Quiver Quantitative | Fund Update: 3,614,465 BAXTER INTERNATIONAL (BAX) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative |
| 2026-04-06 | -0.9% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is Baxter (BAX) Stock Lagging the Market | Price at $16.70, Up 0.15% - Trending Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2024-05-09 | -0.9% | legal | SEC EDGAR | BAX 8-K: 5.02, 5.03, 5.07 (SEC Filing) |
| 2026-01-13 | -0.8% | news | Seeking Alpha | Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2025-11-26 | -0.8% | earnings | Seeking Alpha | Baxter: Temporary Headwinds Mask The Earnings Power Of Its Core Business |
| 2025-11-26 | -0.8% | news | Seeking Alpha | Baxter: Temporary Headwinds; Opportunity For Long-Term Investors (BAX) - Seeking Alpha |
| 2023-08-21 | -0.8% | legal | SEC EDGAR | BAX 8-K: 5.02 and (SEC Filing) |
| 2025-08-26 | -0.8% | news | Trefis | What’s Happening With Baxter International Stock - Trefis |
| 2023-11-02 | +0.7% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | -0.7% | news | Seeking Alpha | Baxter International Inc. (BAX) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript |
| 2024-11-22 | +0.7% | legal | SEC EDGAR | BAX 8-K: 5.02 (SEC Filing) |
| 2025-09-22 | -0.6% | executive | Yahoo Finance | Jim Cramer on Baxter: “They Are the King of Disappointment” - Yahoo Finance |
| 2023-04-27 | +0.6% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2025-11-04 | -0.6% | news | Seeking Alpha | Don't Write Off Baxter Just Yet |
| 2025-11-04 | -0.6% | news | Seeking Alpha | Don't Write Off Baxter Just Yet (NYSE:BAX) - Seeking Alpha |
| 2025-10-25 | -0.5% | news | Yahoo Finance | Baxter International (BAX): Evaluating Value Potential After Steep Share Declines - Yahoo Finance |
| 2023-06-29 | -0.5% | legal | SEC EDGAR | BAX 8-K: 5.02 and (SEC Filing) |
| 2026-01-30 | +0.5% | analyst | Yahoo Finance | Are Wall Street Analysts Predicting Baxter International Stock Will Climb or Sink? - Yahoo Finance |
| 2024-07-18 | +0.5% | legal | SEC EDGAR | BAX 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-02-17 | -0.5% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2022-09-30 | -0.5% | legal | SEC EDGAR | BAX 8-K: 1.01, 7.01 (SEC Filing) |
| 2023-10-03 | -0.4% | legal | SEC EDGAR | BAX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-13 | +0.4% | news | Stock Titan | New Baxter spine table rotates patients 180 degrees during surgery - Stock Titan |
| 2021-11-17 | -0.3% | legal | SEC EDGAR | BAX 8-K: 1.01 and (SEC Filing) |
| 2025-10-21 | -0.3% | legal | SEC EDGAR | BAX 8-K: 5.02 (SEC Filing) |
| 2025-07-07 | -0.3% | legal | SEC EDGAR | BAX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-20 | -0.3% | M&A | The Acquirer's Multiple | Smart Money is Buying Baxter International Inc. (BAX) - The Acquirer's Multiple |
| 2026-04-20 | -0.3% | news | DirectorsTalk Interviews | Baxter International Inc. (BAX) Stock Analysis: Exploring an 18.20% Potential Upside Amidst Healthcare Growth - DirectorsTalk Interviews |
| 2026-04-20 | -0.3% | news | Cổng thông tin điện tử Tỉnh Sơn La | Baxter (BAX) Stock: Is It a Compelling Buy (Investor Interest) 2026-04-20 - Retail Flow - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-20 | -0.3% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Baxter (BAX) Stock: Is It a Compelling Buy (Investor Interest) 2026-04-20 - Retail Flow - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-20 | -0.3% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | Baxter (BAX) Stock: Is It a Compelling Buy (Investor Interest) 2026-04-20 - Earnings Breakout - Cổng thông tin điện tử tỉnh Lào Cai |
| 2021-10-04 | -0.3% | legal | SEC EDGAR | BAX 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2024-02-08 | -0.2% | legal | SEC EDGAR | BAX 8-K: 2.02 and (SEC Filing) |
| 2024-03-21 | +0.1% | legal | SEC EDGAR | BAX 8-K: 1.01 and (SEC Filing) |
| 2025-11-17 | +0.0% | news | GlobeNewswire | Deadline Alert: Baxter International, Inc. (BAX) - GlobeNewswire |
| 2025-12-09 | -0.0% | analyst | Yahoo Finance | Wall Street Analysts Have Consensus Hold Recommendation For Baxter International Inc. (BAX) - Yahoo Finance |
| 2026-03-16 | -0.0% | executive | Seeking Alpha | Baxter CFO Joel Grade to depart |
| 2026-03-16 | -0.0% | legal | SEC EDGAR | BAX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-16 | -0.0% | executive | Stock Titan | CFO shakeup at Baxter: Joel Grade exits, outlook unchanged for 2026 - Stock Titan |
| 2026-03-16 | -0.0% | executive | TipRanks | Baxter International Appoints Interim CFO Amid Leadership Transition - TipRanks |
| 2026-03-16 | -0.0% | executive | GuruFocus | Baxter International (BAX) Announces CFO Transition and Interim Appointment - GuruFocus |
| 2025-08-05 | +0.0% | news | Yahoo Finance | Baxter International Inc. (BAX): A Bull Case Theory - Yahoo Finance |
| 2025-11-18 | +0.0% | news | Seeking Alpha | Baxter International Inc. (BAX) Presents at Jefferies London Healthcare Conference 2025 Transcript |